File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Prognostic factors for transplant-free survival and external validation of prognostic models in Chinese patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy

TitlePrognostic factors for transplant-free survival and external validation of prognostic models in Chinese patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy
Authors
Issue Date2017
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL). Amsterdam, The Netherlands, 19–23 April 2017. In Journal of Hepatology, 2017, v. 66 n. 1, suppl., p. S544 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/246331
ISSN
2023 Impact Factor: 26.8
2023 SCImago Journal Rankings: 9.857
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorCheung, KS-
dc.contributor.authorSeto, WKW-
dc.contributor.authorFung, JYY-
dc.contributor.authorLai, CL-
dc.contributor.authorYuen, RMF-
dc.date.accessioned2017-09-18T02:26:37Z-
dc.date.available2017-09-18T02:26:37Z-
dc.date.issued2017-
dc.identifier.citationThe International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL). Amsterdam, The Netherlands, 19–23 April 2017. In Journal of Hepatology, 2017, v. 66 n. 1, suppl., p. S544-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/246331-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.relation.ispartofThe International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL).-
dc.titlePrognostic factors for transplant-free survival and external validation of prognostic models in Chinese patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy-
dc.typeConference_Paper-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.emailFung, JYY: jfung@hkucc.hku.hk-
dc.identifier.emailLai, CL: hrmelcl@hkucc.hku.hk-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.authorityFung, JYY=rp00518-
dc.identifier.authorityLai, CL=rp00314-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0168-8278(17)31495-2-
dc.identifier.hkuros278518-
dc.identifier.hkuros302561-
dc.identifier.volume66-
dc.identifier.issue1, suppl.-
dc.identifier.spageS544-
dc.identifier.epageS544-
dc.identifier.isiWOS:000401056601338-
dc.publisher.placeNetherlands-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats